Acutus Medical Inc. (AFIB)
OTC: AFIB
· Real-Time Price · USD
0.04
-0.00 (-4.76%)
At close: Apr 04, 2025, 3:23 PM
Acutus Medical Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disposables Revenue | 5.27M | 3.1M | n/a | 3.91M | 3.43M | 3.52M | 2.86M | 3.33M | 3.21M | 2.44M | 2.82M | 1.78M | 2.18M | 1.12M |
| Disposables Revenue Growth | +70.04% | n/a | -100.00% | +14.24% | -2.67% | +23.21% | -14.31% | +3.83% | +31.76% | -13.46% | +57.94% | -18.17% | +94.21% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|
| Non-Us Revenue | 7.66M | 8.94M | 229K |
| Non-Us Revenue Growth | -14.34% | +3803.06% | n/a |
| United States Revenue | 8.71M | 8.32M | n/a |
| United States Revenue Growth | +4.59% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.32M | 2.23M | 3.34M | -12.21M | 7.43M | 9.28M | 9.56M | 9.45M | 9.68M | 14.14M | 14.38M | 15.87M | 15.8M | 15.6M | 16.25M | 15.16M | 15.83M | 9.13M | 10.23M | 7.85M | 7.98M | 6.93M | 4.09M |
| Selling, General, and Administrative Revenue Growth | +4.18% | -33.32% | -127.32% | -264.34% | -19.95% | -2.94% | +1.25% | -2.40% | -31.56% | -1.68% | -9.33% | +0.38% | +1.31% | -4.01% | +7.17% | -4.23% | +73.51% | -10.85% | +30.40% | -1.62% | +15.17% | +69.24% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | -14.23M | 4.79M | 6.8M | 6.12M | 6.27M | 5.95M | 7.93M | 8M | 8.84M | 9.3M | 9.17M | 9.37M | 8.96M | 8.34M | 8.18M | 7.97M | 7.54M | 20.86M | 5.25M | 4.38M |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | -396.77% | -29.47% | +11.15% | -2.42% | +5.43% | -25.07% | -0.85% | -9.47% | -4.94% | +1.36% | -2.09% | +4.55% | +7.42% | +2.04% | +2.55% | +5.74% | -63.86% | +297.66% | +19.88% | n/a |